Company overview
Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small-molecule oral product candidates for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID-19 that are designed to address treatment resistance, such as TRX01 (Ratutrelvir), an inhibitor in development for the treatment of COVID-19; and Tivoxavir marboxil, an endonuclease inhibitor in development for the treatment of bird flu and seasonal influenza. It is also developing narazaciclib, a multi-targeted kinase inhibitor in solid tumors and hematological malignancies as a single agent or in combination with other anti-cancer therapies; and rigosertib, which is administered alone or in combination for investigation in various cancers. It has a license agreement with SymBio Pharmaceuticals Limited, Pint International SA, Viriom, Inc., and Temple University. The company was formerly known as Onconova Therapeutics, Inc. and changed its name to Traws Pharma, Inc. in April 2024. Traws Pharma, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing TRAW with another company.
| Daily close (USD) | $0.48 |
| Market capitalization (USD) | $7,381,383.44 |
| Price / earnings (TTM) | Not reported |
| Price / book | 4.37 |
No matching rows. Clear the filter to see all records.
Read TRAW's valuation metrics
Company size
Traws Pharma, Inc. Common Stock's recorded market capitalization is $7,381,383.44. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
TRAW's recorded price-to-book ratio is 4.37. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Traws Pharma, Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about TRAW. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow TRAW's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.